Skip to main content

Table 3 Final selected radiomics features to identify HER2 expression status

From: Identification of HER2-over-expression, HER2-low-expression, and HER2-zero-expression statuses in breast cancer based on 18F-FDG PET/CT radiomics

Model

Radiomic Feature

HER2-over-expression vs. others

ct_original_shape_MajorAxisLength

 

pet_wavelet-LLL_firstorder_Skewness

 

pet_log-sigma-1-mm-3D_glcm_MCC

 

ct_wavelet-HHH_glszm_ZoneEntropy

 

ct_original_firstorder_Maximum

 

pet_original_glrlm_RunLengthNonUniformityNormalized

 

ct_wavelet-LHH_glszm_LargeAreaHighGrayLevelEmphasis

 

ct_log-sigma-1-mm-3D_glszm_LargeAreaHighGrayLevelEmphasis

HER2-low-expression vs. others

pet_wavelet-HHL_firstorder_Kurtosis

 

ct_wavelet-HHH_glszm_LargeAreaHighGrayLevelEmphasis

 

pet_wavelet-LHH_gldm_DependenceNonUniformityNormalized

 

pet_wavelet-LLL_firstorder_Skewness

 

pet_wavelet-HLH_glcm_JointEnergy

 

ct_wavelet-LLH_glcm_InverseVariance

 

ct_log-sigma-1-mm-3D_glszm_LargeAreaHighGrayLevelEmphasis

 

pet_wavelet-LHH_glszm_GrayLevelNonUniformity

 

ct_wavelet-LLH_glszm_SmallAreaLowGrayLevelEmphasis

 

pet_original_glszm_SmallAreaLowGrayLevelEmphasis

HER2-zero-expression vs. others

pet_wavelet-HHL_glcm_MaximumProbability

 

ct_wavelet-HHH_glszm_ZoneEntropy